您当前的位置:
首页 >
文章列表页 >
Chinese expert consensus on perioperative integrated rehabilitation for radical prostatectomy (2024 edition)
Guideline and Concensus | 更新时间:2025-12-31
    • Chinese expert consensus on perioperative integrated rehabilitation for radical prostatectomy (2024 edition)

    • China Oncology   Vol. 34, Issue 9, Pages: 890-902(2024)
    • DOI:10.19401/j.cnki.1007-3639.2024.09.009    

      CLC: R737.25
    • Received:02 July 2024

      Revised:2024-09-09

      Published:30 September 2024

    移动端阅览

  • of Integrated Rehabilitation for Urogenital Tumors Committee, Anti-Cancer Association Chinese. Chinese expert consensus on perioperative integrated rehabilitation for radical prostatectomy (2024 edition)[J]. China Oncology, 2024, 34(9): 890-902. DOI: 10.19401/j.cnki.1007-3639.2024.09.009.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

1565

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Expert consensus of 177Lu-labeled PSMA radioligand therapy for clinical practice of prostate cancer (2024 edition)
Comparative analysis of whole mount processing and conventional sampling of radical prostatectomy specimens
Mechanism study of MYC promoting proliferation and metastasis in prostate cancer by targeting CD47
MDT consensus on immunotherapy for locally advanced head and neck squamous cell carcinoma (2025 edition)
Expert consensus on diagnosis and treatment of hematologic malignancies with solid tumors (2025 version)

Related Author

Nuclear Medicine Committee of China Anti-Cancer Association Cancer
Association of Nuclear Medicine Physicians Chinese
常坤
杨晓群
王朝夫
甘华磊
郑爱华
杨珺

Related Institution

复旦大学附属肿瘤医院病理科,复旦大学上海医学院肿瘤学系
复旦大学附属肿瘤医院泌尿外科 复旦大学上海医学院肿瘤学系
Department of Urology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology
College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology
Committee of Head and Neck Cancer, Chinese Society of Clinical Oncology
0